RGEN

SEC source: 0000950170-24-025310 · ownership.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,480

F1 · shares: Represents 404 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 24, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.

SEC source: 0000950170-24-025302 · ownership.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,530

F1 · shares: Represents 2,504 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 24, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.

SEC source: 0000950170-24-025296 · ownership.xml · nonDerivative · entry 1

Gebski Christine · CIK 0001849585 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,178

F1 · shares: Represents 391 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 24, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.

SEC source: 0000950170-24-025293 · ownership.xml · nonDerivative · entry 1

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,230

F1 · shares: Represents 404 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 24, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.

SEC source: 0000950170-24-022581 · ownership.xml · derivative · entry 3

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,626 shares

Expires 2028-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0000950170-24-022581 · ownership.xml · nonDerivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,367

SEC source: 0000950170-24-022581 · ownership.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,367

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-023495 · ownership.xml · derivative · entry 2

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,632

Underlying: Common Stock · 8,632 shares

Expires 2034-02-27

F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 27, 2025, February 27, 2026 and February 27, 2027.

SEC source: 0000950170-24-023495 · ownership.xml · nonDerivative · entry 1

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,826

F1 · shares: Mr. Bylund was awarded 8,691 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000950170-24-023489 · ownership.xml · derivative · entry 2

Hunt Anthony · CIK 0001606030 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,585

Underlying: Common Stock · 19,585 shares

Expires 2034-02-27

F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 27, 2025, February 27, 2026 and February 27, 2027.

SEC source: 0000950170-24-023489 · ownership.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,026

F1 · shares: Mr. Hunt was awarded 19,719 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000950170-24-023482 · ownership.xml · derivative · entry 2

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,497

Underlying: Common Stock · 3,497 shares

Expires 2034-02-27

F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 27, 2025, February 27, 2026 and February 27, 2027.

SEC source: 0000950170-24-023482 · ownership.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,076

F1 · shares: Mr. Kuriyel was awarded 3,520 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000950170-24-023417 · ownership.xml · derivative · entry 2

Garland Jason K · CIK 0001754555 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,523

Underlying: Common Stock · 2,523 shares

Expires 2034-02-27

F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 27, 2025, February 27, 2026, and February 27, 2027.

SEC source: 0000950170-24-023417 · ownership.xml · nonDerivative · entry 1

Garland Jason K · CIK 0001754555 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,043

F1 · shares: Mr. Garland was awarded 2,540 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000950170-24-023416 · ownership.xml · derivative · entry 2

Loeillot Olivier · CIK 0001995525 · President and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,860

Underlying: Common Stock · 2,860 shares

Expires 2034-02-27

F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 27, 2025, February 27, 2026 and February 27, 2027.

SEC source: 0000950170-24-023416 · ownership.xml · nonDerivative · entry 1

Loeillot Olivier · CIK 0001995525 · President and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,786

F1 · shares: Mr. Loeillot was awarded 2,880 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000950170-24-020513 · ownership.xml · derivative · entry 3

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 940 shares

Expires 2030-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 2,000 shares vest and become exercisable on both 4/1/2024 and 4/1/2025.

SEC source: 0000950170-24-020513 · ownership.xml · nonDerivative · entry 2

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,135

F1 · price: $198.08 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.73 to $198.46 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0000950170-24-020513 · ownership.xml · nonDerivative · entry 1

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,508

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-23-064504 · ownership.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,307

F1 · kind: The shares were disposed of in connection with a bona fide gift by the Reporting Person to a donor advised fund.

SEC source: 0000950170-23-063113 · ownership.xml · nonDerivative · entry 1

Gebski Christine · CIK 0001849585 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,787

SEC source: 0000950170-23-051753 · ownership.xml · derivative · entry 2

Loeillot Olivier · CIK 0001995525 · President and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,236

Underlying: Common Stock · 24,236 shares

Expires 2033-10-02

F2 · derivative.exercise_date: The shares vest in equal annual installments over a five-year period with each such vesting date occurring on the anniversary of the grant date.

SEC source: 0000950170-23-051753 · ownership.xml · nonDerivative · entry 1

Loeillot Olivier · CIK 0001995525 · President and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,906

F1 · shares: Mr. Loeillot was awarded 12,906 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal installments over a five-year period with each such vesting date occurring on the anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000950170-23-050200 · ownership.xml · derivative · entry 2

Garland Jason K · CIK 0001754555 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,524

Underlying: Common Stock · 10,524 shares

Expires 2033-09-25

F2 · derivative.exercise_date: The shares vest in equal annual installments over a five-year period with each such vesting date occurring on the anniversary of the grant date.

SEC source: 0000950170-23-050200 · ownership.xml · nonDerivative · entry 1

Garland Jason K · CIK 0001754555 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,503

F1 · shares: Mr. Garland was awarded 5,503 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal installments over a five-year period with each such vesting date occurring on the anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000950170-23-045417 · ownership.xml · derivative · entry 3

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,392 shares

Expires 2024-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0000950170-23-045417 · ownership.xml · nonDerivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,741

F1 · price: $171.38 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.37 to $171.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0000950170-23-045417 · ownership.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,591

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-23-013695 · doc4.xml · derivative · entry 3

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,487

Underlying: Common Stock · 1,487 shares

Expires 2033-05-18

F2 · derivative.exercise_date: Award vests in full on the earlier of May 18, 2024, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

SEC source: 0000899243-23-013695 · doc4.xml · nonDerivative · entry 1

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,297

F1 · shares: Mr. Madaus was awarded 686 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 18, 2024, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.

SEC source: 0000899243-23-013692 · doc4.xml · derivative · entry 2

Mhatre Rohin · CIK 0001798735 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,487

Underlying: Common Stock · 1,487 shares

Expires 2033-05-18

F2 · derivative.exercise_date: Award vests in full on the earlier of May 18, 2024, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

SEC source: 0000899243-23-013692 · doc4.xml · nonDerivative · entry 1

Mhatre Rohin · CIK 0001798735 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,345

F1 · shares: Mr. Mhatre was awarded 686 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 18, 2024, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000899243-23-013671 · doc4.xml · derivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,730

Underlying: Common Stock · 1,730 shares

Expires 2033-05-18

F2 · derivative.exercise_date: Award vests in full on the earlier of May 18, 2024, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

SEC source: 0000899243-23-013671 · doc4.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,199

F1 · shares: Ms. Dawes was awarded 798 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 18, 2024, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000899243-23-013670 · doc4.xml · derivative · entry 2

EGLINTON MANNER CARRIE · CIK 0001696776 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,487

Underlying: Common Stock · 1,487 shares

Expires 2033-05-18

F2 · derivative.exercise_date: Award vests in full on the earlier of May 18, 2024, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

SEC source: 0000899243-23-013670 · doc4.xml · nonDerivative · entry 1

EGLINTON MANNER CARRIE · CIK 0001696776 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,167

F1 · shares: Ms. Eglinton Manner was awarded 686 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 18, 2024, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000899243-23-013665 · doc4.xml · derivative · entry 2

Konstantinov Konstantin · CIK 0001774649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,487

Underlying: Common Stock · 1,487 shares

Expires 2033-05-18

F2 · derivative.exercise_date: Award vests in full on the earlier of May 18, 2024, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

SEC source: 0000899243-23-013665 · doc4.xml · nonDerivative · entry 1

Konstantinov Konstantin · CIK 0001774649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,220

F1 · shares: Mr. Konstantinov was awarded 686 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 18, 2024, one year from the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000899243-23-013668 · doc4.xml · derivative · entry 2

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,487

Underlying: Common Stock · 1,487 shares

Expires 2033-05-18

F2 · derivative.exercise_date: Award vests in full on the earlier of May 18, 2024, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

SEC source: 0000899243-23-013668 · doc4.xml · nonDerivative · entry 1

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,767

F1 · shares: Mr. Barthelemy was awarded 686 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 18, 2024, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000899243-23-013667 · doc4.xml · derivative · entry 2

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,487

Underlying: Common Stock · 1,487 shares

Expires 2033-05-18

F2 · derivative.exercise_date: Award vests in full on the earlier of May 18, 2024, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

SEC source: 0000899243-23-013667 · doc4.xml · nonDerivative · entry 1

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,582

F1 · shares: Mr. Muir was awarded 686 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 18, 2024, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0000950170-23-022581 · ownership.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,556

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0000950170-23-022580 · ownership.xml · nonDerivative · entry 1

Gebski Christine · CIK 0001849585 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,575

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0000950170-23-022579 · ownership.xml · nonDerivative · entry 1

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,381

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0000899243-23-012433 · doc4.xml · nonDerivative · entry 4

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,611

F4 · price: $156.18 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $156.10 to $156.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.

F6 · ownership.direct: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control.

SEC source: 0000899243-23-012433 · doc4.xml · nonDerivative · entry 3

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,111

F3 · price: $159.19 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $158.96 to $159.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.

F6 · ownership.direct: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control.

SEC source: 0000899243-23-012433 · doc4.xml · nonDerivative · entry 2

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 611

F2 · price: $161.15 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $160.85 to $161.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.

F6 · ownership.direct: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control.

SEC source: 0000899243-23-010599 · doc4.xml · nonDerivative · entry 1

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,568

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.